Login to Your Account



Gilead Begins Phase II/III Studies Of Oral Influenza Drug


Wednesday, December 17, 1997
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription